In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS

Antimicrob Agents Chemother. 1995 Jun;39(6):1386-7. doi: 10.1128/AAC.39.6.1386.

Abstract

In vitro susceptibilities of Mycoplasma penetrans were determined. MICs and MBCs were determined. The MICs at which 50% of the isolates are inhibited (micrograms per milliliter) for broth dilution testing were as follows: azithromycin, 0.039; chloramphenicol, 0.625; ciprofloxacin, 0.156; clindamycin, 0.078; doxycycline, 0.312; erythromycin, 0.312; gentamicin. > 10; levofloxacin, 0.078; lincomycin, 0.625; streptomycin, > 10; and tetracycline, 1.25. Bactericidal activity was significant only for ciprofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml) and levofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml).

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / drug therapy
  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Anti-Bacterial Agents / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Mycoplasma Infections / complications
  • Mycoplasma Infections / drug therapy
  • Mycoplasma penetrans / drug effects*

Substances

  • Anti-Bacterial Agents